EpiGene is rated 3 out of 5 in the category biotechnology. Read and write reviews about EpiGene. EpiGene - spin-off company of SibEnzyme, developing next generation epigenetic tests for early cancer detection. Skolkovo resident. Nanocenter SYGMA is our financial investor. Today we've finished development of tests for early detection of lung, breast, stomach and colon cancers. Looking for partners to go worldwide.
Address
Inzhenernaya str., 18
Company size
11-50 employees
Headquarters
Novosibirsk, Novosibirsk region